These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Treatment success rate among Iranian opioid dependents. Ahmadi J, Motamed F. Subst Use Misuse; 2003 Jan; 38(1):151-63. PubMed ID: 12602812 [Abstract] [Full Text] [Related]
5. Prevalence, demographic and clinical characteristics of body dysmorphic disorder among psychiatric outpatients with mood, anxiety or somatoform disorders. van der Meer J, van Rood YR, van der Wee NJ, den Hollander-Gijsman M, van Noorden MS, Giltay EJ, Zitman FG. Nord J Psychiatry; 2012 Sep; 66(4):232-8. PubMed ID: 22029732 [Abstract] [Full Text] [Related]
7. Methadone maintenance outcome as a function of detoxification phobia. Milby JB, Hohmann AA, Gentile M, Huggins N, Sims MK, McLellan AT, Woody G, Haas N. Am J Psychiatry; 1994 Jul; 151(7):1031-7. PubMed ID: 8010360 [Abstract] [Full Text] [Related]
12. Belief in life after death and mental health: findings from a national survey. Flannelly KJ, Koenig HG, Ellison CG, Galek K, Krause N. J Nerv Ment Dis; 2006 Jul; 194(7):524-9. PubMed ID: 16840849 [Abstract] [Full Text] [Related]
14. Diagnostic overlap of depressive, anxiety, stress and somatoform disorders in primary care. Bener A, Al-Kazaz M, Ftouni D, Al-Harthy M, Dafeeah EE. Asia Pac Psychiatry; 2013 Mar; 5(1):E29-38. PubMed ID: 23857793 [Abstract] [Full Text] [Related]
15. A naturalistic exploratory study of the impact of demographic, phenotypic and comorbid features in pediatric obsessive-compulsive disorder. Masi G, Millepiedi S, Perugi G, Pfanner C, Berloffa S, Pari C, Mucci M, Akiskal HS. Psychopathology; 2010 Mar; 43(2):69-78. PubMed ID: 20068377 [Abstract] [Full Text] [Related]